Skip to main content
Top

Current Treatment Options in Oncology

Issue 1/2019

Content (9 Articles)

Cetuximab Head and Neck Cancer (CP Rodriguez, Section Editor)

Therapeutic Intensification and Induction Chemotherapy for High-Risk Locally Advanced Squamous Cell Carcinoma

Maria Grazia Ghi, Adriano Paccagnella

Systemic Therapy Upper Gastrointestinal Cancers (L Rajdev, Section Editor)

Systemic Therapy for Advanced Hepatocellular Carcinoma in an Evolving Landscape

Kabir Mody, Ghassan K. Abou-Alfa

Brain Tumor Neuro-oncology (GJ Lesser, Section Editor)

Guidelines for Treatment and Monitoring of Adult Survivors of Pediatric Brain Tumors

Anna J. Janss, Claire Mazewski, Briana Patterson

Acute Lymphoblastic Leukemia Leukemia (PH Wiernik, Section Editor)

Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Iman Abou Dalle, Elias Jabbour, Nicholas J. Short, Farhad Ravandi

Anemia Leukemia (PH Wiernik, Section Editor)

New Concepts of Treatment for Patients with Myelofibrosis

Prithviraj Bose, Mansour Alfayez, Srdan Verstovsek

Blastic Plasmacytoid Dendritic Cell Neoplasm Leukemia (PH Wiernik, Section Editor)

Blastic Plasmacytoid Dendritic Cell Neoplasm

Daniel Kerr II, Ling Zhang, Lubomir Sokol

Liposarcoma Sarcoma (SH Okuno, Section Editor)

First-Line Therapy for Metastatic Soft Tissue Sarcoma

Megan Meyer, Mahesh Seetharam

Open Access Melanoma Skin Cancer (T Ito, Section Editor)

Targeted Therapy and Immunotherapy for Melanoma in Japan

Kenjiro Namikawa, Naoya Yamazaki

Colon Cancer Lower Gastrointestinal Cancers (AB Benson, Section Editor)

The Optimal Duration of Adjuvant Therapy for Stage III Colon Cancer: the European Perspective

Giacomo Bregni, Sara Elena Rebuzzi, Alberto Sobrero

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine